Literature DB >> 8404174

The ventilatory response to arm elevation of patients with chronic obstructive pulmonary disease.

T E Dolmage1, L Maestro, M A Avendano, R S Goldstein.   

Abstract

Although arm activity is poorly tolerated by patients with COPD, the ventilatory response to arm elevation alone is not well understood. We therefore studied the ventilatory response to arm elevation using a customized arm support sling to eliminate the effect of an increase in metabolic activity that might be attributable to independent arm elevation and used leg exercise to increase metabolic activity. During arm elevation at rest, there was a significant decrease in vital capacity (180 ml) and a small decrease in functional residual capacity (120 ml) as measured by body plethysmography. Minute ventilation was unchanged. When supported arm elevation (SAE) was compared with the control arm position (CAP), minute ventilation was unchanged although the pattern of breathing became more rapid and shallow (mean +/- SD, SAE vs CAP: fb = 17.9 +/- 5.3 vs 16.2 +/- 4.8 breaths.min-1; VT = 533 +/- 126 vs 579 +/- 142 ml; p < 0.05). During steady-state leg exercise, the increase in VO2, VCO2 and VE did not differ between SAE and CAP; however, both fb and VT changed toward a more rapid, shallow pattern of breathing (SAE vs CAP: fb = 24.3 +/- 3.0 vs 22.8 +/- 3.5 breaths.min-1; VT = 990 +/- 293 vs 1,081 +/- 309 ml; p < 0.05). During unsupported arm elevation VO2, VCO2, and VE, and fb were significantly greater than during the CAP. Approaches that train arm muscles and strategies that either support arm muscles or allow for frequent rests during upper arm activity may improve the endurance and the quality of life for COPD patients.

Entities:  

Mesh:

Year:  1993        PMID: 8404174     DOI: 10.1378/chest.104.4.1097

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Effect of upper extremity exercise in people with COPD.

Authors:  Ganesan Kathiresan; Senthil Kumar Jeyaraman; Jayachandran Jaganathan
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

2.  Reference values for assessing the arms: are we seeing a light at the end of the tunnel?

Authors:  Luciana Dias Chiavegato
Journal:  J Bras Pneumol       Date:  2018 May-Jun       Impact factor: 2.624

3.  The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease.

Authors:  Kenichi Takeda; Yuji Kawasaki; Kazumasa Yoshida; Yoji Nishida; Tomoya Harada; Kosuke Yamaguchi; Shizuka Ito; Kiyoshi Hashimoto; Shingo Matsumoto; Akira Yamasaki; Tadashi Igishi; Eiji Shimizu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-07-23

4.  Posture and mobility of the upper body quadrant and pulmonary function in COPD: an exploratory study.

Authors:  Nuno Morais; Joana Cruz; Alda Marques
Journal:  Braz J Phys Ther       Date:  2016-04-08       Impact factor: 3.377

5.  Physiological responses to arm versus leg activity in patients with chronic obstructive pulmonary disease: a systematic review protocol.

Authors:  Tania Janaudis-Ferreira; Andre Nyberg; Erik Frykholm; Vanessa Pereira Lima
Journal:  BMJ Open       Date:  2018-02-21       Impact factor: 2.692

6.  Metronome-Paced Incremental Hyperventilation May Predict Exercise Tolerance and Dyspnea as a Surrogate for Dynamic Lung Hyperinflation During Exercise.

Authors:  Shohei Kawachi; Keisaku Fujimoto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-15

7.  Ventilatory requirements of quadriceps resistance training in people with COPD and healthy controls.

Authors:  Linzy Houchen-Wolloff; Carolyn J Sandland; Samantha L Harrison; Manoj K Menon; Mike D Morgan; Michael C Steiner; Sally J Singh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-05

8.  Reference value for the six-minute peg board and ring test. A cross sectional study.

Authors:  Manjiri Suhas Kulkarni; Gopala Krishna Alaparthi; Shyam Krishnan; Anand Ramakrishna; Vishak Acharya
Journal:  Multidiscip Respir Med       Date:  2020-06-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.